Skin Cancer Channel
Topics
Medications
Quicklinks
Related Channels

DTIC-Dome Drug Information

DTIC-Dome® (dacarbazine) is a chemotherapy drug specifically approved for treating malignant melanoma (a type of skin cancer) when it has spread to other areas (metastasized). It is also approved for use in combination with other medications to treat Hodgkin's disease.
 
This medication comes as an injection that given intravenously (by IV) once a day for 5 to 10 days, followed by a break in treatment. Most people who use this medicine will experience some type of side effect, such as nausea, vomiting, or loss of appetite.
 
Although DTIC-Dome may be a helpful cancer treatment, not everyone can use it. The drug's safety information should be discussed with your healthcare provider before starting treatment to minimize your risk for certain complications. For instance, people who have problems with their kidneys or liver may not be able to safely use this medicine.
 
(Click DTIC-Dome for more information on this drug, including how it works, dosing tips, and available strengths.)
 
 

DTIC-Dome Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.